| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 3 |
| 1 | VEDOLIZUMAB | 3 |
| 2 | RAMIPRIL | 2 |
| 3 | RITUXIMAB | 2 |
| 4 | AMLODIPINE | 1 |
| 5 | ASPIRIN | 1 |
| 6 | ASPIRIN 325 MG | 1 |
| 7 | ASPIRIN 81 MG | 1 |
| 8 | CYCLOPHOSPHAMIDE | 1 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMIQUIMOD | 1 | 0.0004 |
| 1 | VEDOLIZUMAB | 3 | 0.0000 |
| 2 | ENALAPRIL | 1 | 0.0000 |
| 3 | RAMIPRIL | 2 | 0.0000 |
| 4 | INFLIXIMAB | 3 | 0.0000 |
| 5 | HYDROXYCHLOROQUINE SULFATE | 1 | 0.0000 |
| 6 | USTEKINUMAB | 1 | 0.0000 |
| 7 | RITUXIMAB | 2 | 0.0000 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 | 0.0000 |
| 9 | CYCLOPHOSPHAMIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 1 | Angiotensin Converting Enzyme Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 3 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 6 | Proton Pump Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 3 | 0.0000 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |